Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangi...
Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
About this item
Full title
Author / Creator
Publisher
American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
Propranolol and atenolol, current therapies for problematic infantile hemangioma (IH), are composed of R(+) and S(-) enantiomers: the R(+) enantiomer is largely devoid of beta blocker activity. We investigated the effect of R(+) enantiomers of propranolol and atenolol on the formation of IH-like blood vessels from hemangioma stem cells (HemSCs) in...
Alternative Titles
Full title
Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A693733738
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A693733738
Other Identifiers
ISSN
0021-9738
DOI
10.1172/JCI151109.
